Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity

Multidrug-resistant bacteria cause severe infections in hospitals and communities. Development of new drugs to combat resistant microorganisms is needed. Natural products of microbial origin are the source of most currently available antibiotics. We hypothesized that random mutagenesis of Aspergill...

Full description

Saved in:
Bibliographic Details
Main Authors: Cory A. Leonard, Stacy D. Brown, J. Russell Hayman
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Microbiology
Online Access:http://dx.doi.org/10.1155/2013/901697
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555526829899776
author Cory A. Leonard
Stacy D. Brown
J. Russell Hayman
author_facet Cory A. Leonard
Stacy D. Brown
J. Russell Hayman
author_sort Cory A. Leonard
collection DOAJ
description Multidrug-resistant bacteria cause severe infections in hospitals and communities. Development of new drugs to combat resistant microorganisms is needed. Natural products of microbial origin are the source of most currently available antibiotics. We hypothesized that random mutagenesis of Aspergillus oryzae would result in secretion of antibacterial compounds. To address this hypothesis, we developed a screen to identify individual A. oryzae mutants that inhibit the growth of Methicillin-resistant Staphylococcus aureus (MRSA) in vitro. To randomly generate A. oryzae mutant strains, spores were treated with ethyl methanesulfonate (EMS). Over 3000 EMS-treated A. oryzae cultures were tested in the screen, and one isolate, CAL220, exhibited altered morphology and antibacterial activity. Culture supernatant from this isolate showed antibacterial activity against Methicillin-sensitive Staphylococcus aureus, MRSA, and Pseudomonas aeruginosa, but not Klebsiella pneumonia or Proteus vulgaris. The results of this study support our hypothesis and suggest that the screen used is sufficient and appropriate to detect secreted antibacterial fungal compounds resulting from mutagenesis of A. oryzae. Because the genome of A. oryzae has been sequenced and systems are available for genetic transformation of this organism, targeted as well as random mutations may be introduced to facilitate the discovery of novel antibacterial compounds using this system.
format Article
id doaj-art-454c9eee7715469f851106c91eab0a07
institution Kabale University
issn 1687-918X
1687-9198
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Microbiology
spelling doaj-art-454c9eee7715469f851106c91eab0a072025-02-03T05:48:01ZengWileyInternational Journal of Microbiology1687-918X1687-91982013-01-01201310.1155/2013/901697901697Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial ActivityCory A. Leonard0Stacy D. Brown1J. Russell Hayman2Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, P.O. Box 70577, Johnson City, TN 37614, USADepartment of Pharmaceutical Sciences, Bill Gatton College of Pharmacy, East Tennessee State University, P.O. Box 70436, Johnson City, TN 37614, USADepartment of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, P.O. Box 70577, Johnson City, TN 37614, USAMultidrug-resistant bacteria cause severe infections in hospitals and communities. Development of new drugs to combat resistant microorganisms is needed. Natural products of microbial origin are the source of most currently available antibiotics. We hypothesized that random mutagenesis of Aspergillus oryzae would result in secretion of antibacterial compounds. To address this hypothesis, we developed a screen to identify individual A. oryzae mutants that inhibit the growth of Methicillin-resistant Staphylococcus aureus (MRSA) in vitro. To randomly generate A. oryzae mutant strains, spores were treated with ethyl methanesulfonate (EMS). Over 3000 EMS-treated A. oryzae cultures were tested in the screen, and one isolate, CAL220, exhibited altered morphology and antibacterial activity. Culture supernatant from this isolate showed antibacterial activity against Methicillin-sensitive Staphylococcus aureus, MRSA, and Pseudomonas aeruginosa, but not Klebsiella pneumonia or Proteus vulgaris. The results of this study support our hypothesis and suggest that the screen used is sufficient and appropriate to detect secreted antibacterial fungal compounds resulting from mutagenesis of A. oryzae. Because the genome of A. oryzae has been sequenced and systems are available for genetic transformation of this organism, targeted as well as random mutations may be introduced to facilitate the discovery of novel antibacterial compounds using this system.http://dx.doi.org/10.1155/2013/901697
spellingShingle Cory A. Leonard
Stacy D. Brown
J. Russell Hayman
Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity
International Journal of Microbiology
title Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity
title_full Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity
title_fullStr Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity
title_full_unstemmed Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity
title_short Random Mutagenesis of the Aspergillus oryzae Genome Results in Fungal Antibacterial Activity
title_sort random mutagenesis of the aspergillus oryzae genome results in fungal antibacterial activity
url http://dx.doi.org/10.1155/2013/901697
work_keys_str_mv AT coryaleonard randommutagenesisoftheaspergillusoryzaegenomeresultsinfungalantibacterialactivity
AT stacydbrown randommutagenesisoftheaspergillusoryzaegenomeresultsinfungalantibacterialactivity
AT jrussellhayman randommutagenesisoftheaspergillusoryzaegenomeresultsinfungalantibacterialactivity